Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars

• Auteurs principaux: Alina Uifălean (Auteur), Maria Ilieş (Auteur), Raul Nicoară (Auteur), Lucia Maria Rus (Auteur), Simona Codruţa Hegheş (Auteur), Cristina-Adela Iuga (Auteur)
• Format: Livre
• Publié: MDPI AG, 2018-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

With the development of anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibodies, trastuzumab-based therapy has become the standard of care among patients with early or advanced HER2-positive breast cancer. However, real-world data have shown that up to a half of patients do not re...